Improving Safety By Computerizing Outpatient Prescribing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00235027|
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : July 21, 2015
|Condition or disease||Intervention/treatment||Phase|
|Impact of Electronic Prescribing on Medication Safety||Other: Adverse Drug Event Monitoring||Not Applicable|
Specific Aim 1: Increase routine identification of outpatient adverse drug events (ADEs) through development of a computerized ADE detection monitor.
Specific Aim 2: Use basic computerized outpatient prescribing to reduce preventable ADEs in a diverse array of outpatient settings.
Specific Aim 3: Use advanced decision-support within computerized prescribing to reduce the frequency of preventable ADEs, medication errors, and potential ADEs.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||701 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Improving Safety By Computerizing Outpatient Prescribing|
|Study Start Date :||August 2000|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||December 2010|
Experimental: Adverse Drug Event Monitoring
In this intervention arm, clinicians received medication safety alerts when they prescribed medications in the electronic medical record.
Other: Adverse Drug Event Monitoring
The intervention in this study is the presentation of medication safety alerts in the electronic medical record to improve patient outcomes and safety.
No Intervention: Care as Usual
In this arm, clinicians did not receive the medication safety alerts.
- Preventable Adverse drug events [ Time Frame: 8/5/2004 - 1/5/2005 ]Data were electronically collected each time a physician entered a prescription that triggered an alert related to medication safety.
- Total adverse drug events, medication errors [ Time Frame: 1/15/2001 - 5/15/2001 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235027
|United States, Indiana|
|Indianapolis, Indiana, United States|
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02115|
|Study Director:||Tejal K Gandhi, MD, MPH||Brigham and Women's Hospital|
|Principal Investigator:||David Bates, MD||Brigham and Women's Hospital|
|Study Director:||Marc Overhage, MD||Regenstrief Institute, Inc.|